COVID-19 is modernising the way we run clinical trials: what will happen next?
The biopharmaceutical industry and regulatory authorities have been working to ensure clinical trials have been progressing in all diseases throughout the global pandemic. When the COVID-19 pandemic began, most of our focus went to ‘how can my family and I stay safe?’ and ‘will we have medicines and vaccines that will treat or protect us?’...
3 min read